Access expired on Wednesday, July 17, 2019
This content was originally shared by a registered user, but access has expired. Create a free account to gain permanent access to all PracticeUpdate content.
Already Have An Account? Log in Now
story of the week
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
N. Engl. J. Med 2019 Jun 02;[EPub Ahead of Print], T Golan, P Hammel, M Reni, E Van Cutsem, T Macarulla, MJ Hall, JO Park, D Hochhauser, D Arnold, DY Oh, A Reinacher-Schick, G Tortora, H Algül, EM O'Reilly, D McGuinness, KY Cui, K Schlienger, GY Locker, HL KindlerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.